As of 2024-12-12, the Intrinsic Value of Anavex Life Sciences Corp (AVXL) is
-2.45 USD. This Anavex valuation is based on the model Peter Lynch Fair Value.
With the current market price of 8.38 USD, the upside of Anavex Life Sciences Corp is
-129.22%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-2.45 USD
Intrinsic Value
Anavex Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-2.45 - -2.45 |
-2.45 |
-129.22% |
| P/E |
(5.57) - (9.59) |
(9.13) |
-209.0% |
| DDM - Stable |
(2.71) - (6.81) |
(4.76) |
-156.8% |
| DDM - Multi |
(2.73) - (5.44) |
(3.64) |
-143.5% |
Anavex Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
710.62 |
| Beta |
2.50 |
| Outstanding shares (mil) |
84.80 |
| Enterprise Value (mil) |
571.87 |
| Market risk premium |
4.60% |
| Cost of Equity |
13.56% |
| Cost of Debt |
5.00% |
| WACC |
9.27% |